Department of Defense influenza and other respiratory disease surveillance during the 2009 pandemic

BMC Public Health

Review

Kevin L Russell¹  David L Blazes¹  Ronald L Burke¹  Angelia A Eick¹  Kelly G Vest¹  Matthew C Johns¹  Jose L Sanchez¹  Richard G Jarman²  Julie A Pavlin²  Jerry L Mothershead³  Alisa Wilma⁴  Candelaria Daniels⁴  Gregory C Gray⁵  Thomas Palys⁶  Randal J Schoepp⁷  David A Norwood⁷  Anthony Hawksworth⁸  Patrick J Blair⁸  Joel M Montgomery⁹  Alberto Laguna-Torres⁹  Hugo Razuri⁹  Buhari Oyofo^1,10  Jeffrey A Tjaden^1,10  Steven Tobias^1,11  Maya Williams^1,11  Matthew R Kasper^1,11  Michael J Cooper^1,12  Jian Guan^1,13  Miguel Quintana^1,14  Victor H MacIntosh^1,15  Thomas Gibbons^1,15  David Schnabel^1,16  John Waitumbi^1,16  Timothy Styles^1,17  Matthew L Brown^1,18 

[1] Armed Forces Health Surveillance Center, 503 Robert Grant Avenue, 20910, Silver Spring, MD, USA;Armed Forces Research Institute of Medical Sciences, 315/6 Rajavithi Road, 10400, Bangkok, Thailand;Center for Disaster and Humanitarian Assistance Medicine, Uniformed Services University of the Health Sciences, F. Edward Hébert School of Medicine, 4301 Jones Bridge Road, 20814, Bethesda, MD, USA;Department of Defense Veterinary Food Analysis & Diagnostic Laboratory, 2472 Schofield Road, Suite 2630, 78234, Fort Sam Houston, TX, USA;Department of Environmental and Global Health, College of Public Health and Health Professions, University of Florida, Post Office Box 100188, 32610, Gainesville, FL, USA;Department of Pathology and Area Laboratory Services, CMR 402, Landstuhl Regional Medical Center, APO AE 09180, USA;Diagnostic Systems Division, U.S. Army Medical Research Institute of Infectious Diseases, 1425 Porter Street, 21702, Fort Detrick, MD, USA;Naval Health Research Center, 140 Sylvester Road, 92106, San Diego, CA, USA;Naval Medical Research Center Detachment, Centro Medico Naval “CMST, Av. Venezuela CDRA 36, Callao 2, Lima, Peru;Naval Medical Research Unit No. 3, Adjacent to Abbassia Fever Hospital, Extension of Ramses Street, Postal Code 11517, Cairo, Egypt;Naval Medical Research Unit Number 2, Kompleks Pergudangan DEPKES R.I., JI. Percetakan Negara II No. 23, 10560, Jakarta, Indonesia;Public Health Region-Europe, CMR 402, APO AE 09180, USA;Public Health Region-Pacific, Unit 45006, APO AE 96343, USA;Public Health Region-South, Building 2472, Schofield Road, 78234, Fort Sam Houston, TX, USA;U.S. Air Force School of Aerospace Medicine, 2513 Kennedy Circle, Building 180, 78235, Brooks City Base, TX, USA;U.S. Embassy, Attention: MRU, Post Office Box 606, United Nations Avenue, Village Market, 00621, Nairobi, Kenya;U.S. Navy Environmental Preventive Medicine Unit No. 2, 1887 Powhatan Street, 23511, Norfolk, VA, USA;USAMEDDAC-Korea, Microbiology Section, Unit 15244, Box 459, APO AP 96205, USA;

关键词: Influenza;    Influenza Pandemic;    Highly Pathogenic Avian Influenza;    Influenza Surveillance;    Military Health System;   

DOI  :  10.1186/1471-2458-11-S2-S6

来源: Springer

【 摘 要 】

The Armed Forces Health Surveillance Center’s Division of Global Emerging Infections Surveillance and Response System (AFHSC-GEIS) supports and oversees surveillance for emerging infectious diseases, including respiratory diseases, of importance to the U.S. Department of Defense (DoD). AFHSC-GEIS accomplishes this mission by providing funding and oversight to a global network of partners for respiratory disease surveillance. This report details the system’s surveillance activities during 2009, with a focus on efforts in responding to the novel H1N1 Influenza A (A/H1N1) pandemic and contributions to global public health. Active surveillance networks established by AFHSC-GEIS partners resulted in the initial detection of novel A/H1N1 influenza in the U.S. and several other countries, and viruses isolated from these activities were used as seed strains for the 2009 pandemic influenza vaccine. Partners also provided diagnostic laboratory training and capacity building to host nations to assist with the novel A/H1N1 pandemic global response, adapted a Food and Drug Administration-approved assay for use on a ruggedized polymerase chain reaction platform for diagnosing novel A/H1N1 in remote settings, and provided estimates of seasonal vaccine effectiveness against novel A/H1N1 illness. Regular reporting of the system’s worldwide surveillance findings to the global public health community enabled leaders to make informed decisions on disease mitigation measures and controls for the 2009 A/H1N1 influenza pandemic. AFHSC-GEIS’s support of a global network contributes to DoD’s force health protection, while supporting global public health.

【 授权许可】

CC BY   
© Burke et al; licensee BioMed Central Ltd. 2011